Literature DB >> 28003635

Effects of STAT3 inhibitors on neural functional recovery after spinal cord injury in rats.

Meng Cui1, Xinlong Ma, Jie Sun, Jinquan He, Lin Shen, Fangguo Li.   

Abstract

Spinal cord injuries (SCIs) can induce primary and secondary injury, resulting in severe neurological damage and dysfunction in patients. Studies have reported that signal transducer and activator of transcription 3 (STAT3) plays an important role in the inflammatory immune response and neural stem cell differentiation. In order to examine whether a STAT3 inhibitor can prevent worsening of an SCI and promote neural stem cell differentiation, a rat model of surgically induced SCI was created and rats were treated with the STAT3 inhibitor S31-201. Tissue from the injured region was harvested and fixed in formalin and paraffin. H&E staining was used to look for morphological changes. The Basso, Beattie, and Bresnahan locomotor scale (BBB score), somatosensory evoked potentials (SEP), and motor evoked potentials (MEP) were examined. Western blotting was used to detect the expression of β-tubulin ш, vimentin, GFAP, NF-200, and OX-42 protein. Results indicated that the STAT3 inhibitor S31-201 reduces the extent of SCI and it promotes neural stem cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28003635     DOI: 10.5582/bst.2016.01160

Source DB:  PubMed          Journal:  Biosci Trends        ISSN: 1881-7815            Impact factor:   2.400


  6 in total

1.  Exosomes Derived from lncRNA TCTN2-Modified Mesenchymal Stem Cells Improve Spinal Cord Injury by miR-329-3p/IGF1R Axis.

Authors:  Jian Liu; Mingxia Lin; Feng Qiao; Chenghua Zhang
Journal:  J Mol Neurosci       Date:  2021-10-08       Impact factor: 3.444

2.  LncRNA DGCR5 suppresses neuronal apoptosis to improve acute spinal cord injury through targeting PRDM5.

Authors:  Huafeng Zhang; Wengang Wang; Ning Li; Peng Li; Ming Liu; Junwei Pan; Dan Wang; Junwei Li; Yuanyuan Xiong; Lei Xia
Journal:  Cell Cycle       Date:  2018-09-11       Impact factor: 4.534

3.  Inhibition of JAK1/2 Tyrosine Kinases Reduces Neurogenic Heterotopic Ossification After Spinal Cord Injury.

Authors:  Kylie A Alexander; Hsu-Wen Tseng; Whitney Fleming; Beulah Jose; Marjorie Salga; Irina Kulina; Susan M Millard; Allison R Pettit; François Genêt; Jean-Pierre Levesque
Journal:  Front Immunol       Date:  2019-03-07       Impact factor: 7.561

4.  Promoting functions of microRNA-29a/199B in neurological recovery in rats with spinal cord injury through inhibition of the RGMA/STAT3 axis.

Authors:  Weijie Yang; Ping Sun
Journal:  J Orthop Surg Res       Date:  2020-09-18       Impact factor: 2.359

5.  S100-β aggravates spinal cord injury via activation of M1 macrophage phenotype.

Authors:  Keke Duan; Shizhang Liu; Zhi Yi; Huitong Liu; Jingyuan Li; Jiyuan Shi; Le Ji; Bingqiang Xu; Xiaoxia Zhang; Wei Zhang
Journal:  J Musculoskelet Neuronal Interact       Date:  2021-09-01       Impact factor: 2.041

Review 6.  Novel perspectives on the therapeutic role of cryptotanshinone in the management of stem cell behaviors for high-incidence diseases.

Authors:  Xiaomeng Guo; Ruishuang Ma; Meng Wang; Benson Wui-Man Lau; Xiaopeng Chen; Yue Li
Journal:  Front Pharmacol       Date:  2022-08-15       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.